New Test Identifies Patients Whose Postoperative Pain can be Treated by Hypnosis
Investigators developed a molecular test that identifies individuals most likely to benefit from hypnosis interventions to treat pain.
Read MorePosted by Andy Lundin | Mar 14, 2023 | Molecular Diagnostics |
Investigators developed a molecular test that identifies individuals most likely to benefit from hypnosis interventions to treat pain.
Read MorePosted by Andy Lundin | Mar 13, 2023 | Hematology & Serology, Tuberculosis |
A research team discovered new technology that will quickly and easily detect active Mycobacterium tuberculosis (TB) infection antibodies.
Read MorePosted by Andy Lundin | Mar 10, 2023 | Covid 19 |
QuidelOrtho has been granted a De Novo request from the U.S. FDA, allowing the company to market its new Sofia 2 SARS Antigen+ FIA.
Read MorePosted by Andy Lundin | Mar 8, 2023 | Clinical Chemistry Analyzers, Urine Analyzers |
Shenzhen Superbio Technology received FDA clearance for its point-of-care instrument intended for the detection of fentanyl in human urine.
Read MorePosted by Andy Lundin | Mar 7, 2023 | Covid 19 |
A recent University of Michigan study suggests that a patient’s breath might hold the key to a more precise diagnosis of COVID
Read More